These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1016567)

  • 1. [Acetylsalicylic acid and platelet aggregation. Clinical study].
    Bertulla A; Riva A
    Ateneo Parmense Acta Biomed; 1976; 47(6):707-19. PubMed ID: 1016567
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antiaggregant therapy in cerebrovascular insufficiency in the aged].
    Fabris F; Pernigotti L
    Clin Ter; 1979 Jan; 88(1):21-31. PubMed ID: 35301
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use].
    Croveri G
    Minerva Cardioangiol; 1980 Oct; 28(10):723-6. PubMed ID: 7465066
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of thrombocyte aggregation on heart valve prostheses using acetylsalicylic acid].
    Mühe E; von der Emde J; Raithel D
    Med Welt; 1971 Aug; 35():1335-6. PubMed ID: 4935448
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-platelet aggregation action and paradoxical effects of acetylsalicylic acid].
    Mocchi N; Sbalzarini G; Cantaluppi P
    Clin Ter; 1985 Jul; 114(1):37-41. PubMed ID: 4042578
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of acetylsalicylic acid in the overall therapy of the severe form of hemorrhagic fever with renal syndrome].
    Abdurashitov RF
    Klin Med (Mosk); 1980 May; 58(5):53-7. PubMed ID: 6103975
    [No Abstract]   [Full Text] [Related]  

  • 7. [Association of hemorrhagic and thrombotic phenomena in myeloproliferative syndromes].
    Meschengieser SS; Woods AI; Schattner MA; Lazzari MA
    Medicina (B Aires); 1981; 41 Suppl():267-73. PubMed ID: 6954340
    [No Abstract]   [Full Text] [Related]  

  • 8. [Erythrocyte and thrombocyte aggregation disorders in the pathogenesis of diabetic retinopathy and the potentials of disaggregation therapy].
    Tartakovskaia AI; Arkhangel'skaia EN; Dudnikova LK
    Vestn Oftalmol; 1983; (6):59-62. PubMed ID: 6659243
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of the results obtained in thromboembolic vascular lesions with 2 platelet aggregation inhibitors].
    Parisi FR; Raso AM; Fiorio C; Salvetti M
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1983; 32(4):293-6. PubMed ID: 6150522
    [No Abstract]   [Full Text] [Related]  

  • 10. Measurement of shear-activated platelet aggregate formation in non-anticoagulated blood: utility in detection of clopidogrel-aspirin-induced platelet dysfunction.
    Johnson GJ; Sharda AV; Rao GH; Ereth MH; Laxson DD; Owen WG
    Clin Appl Thromb Hemost; 2012; 18(2):140-9. PubMed ID: 22009986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of combinations of acetylsalicylic acid, acetaminophen, and diclofenac on platelet aggregation.
    Galliard-Grigioni KS; Fehr M; Reinhart WH
    Eur J Pharmacol; 2008 Oct; 595(1-3):65-8. PubMed ID: 18700139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral simultaneous anterior ischaemic optic neuropathy associated with Sticky Platelet Syndrome.
    Mears KA; Van Stavern GP
    Br J Ophthalmol; 2009 Jul; 93(7):885-6, 913. PubMed ID: 18662911
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of naftidrofuryl and aspirin on platelet aggregation in peripheral vascular disease.
    Barradas MA; Stansby G; Hamilton G; Mikhailidis DP
    In Vivo; 1993; 7(6A):543-8. PubMed ID: 8193274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acetylsalicylic acid in the treatment of ischemic cerebrovascular disorders].
    Caneschi S; Bonaventi C; Finzi F; Tito P
    Minerva Med; 1986 Jun; 77(27):1299-308. PubMed ID: 3523307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemorheological background of acetylsalicylic acid resistance.
    Feher G; Koltai K; Kesmarky G; Toth K
    Clin Hemorheol Microcirc; 2008; 38(3):143-52. PubMed ID: 18239256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of speed of an anti-platelet effect after two different doses of acetylsalicylic acid by flocculation].
    Malý M; Vojácek J; Hadacová I; Mates M; Hájek P; Durdil V
    Vnitr Lek; 2004 Jun; 50(6):428-33. PubMed ID: 15346635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
    Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of necrobiosis lipoidica with low-dose acetylsalicylic acid. A randomized double-blind trial.
    Beck HI; Bjerring P; Rasmussen I; Zachariae H; Stenbjerg S
    Acta Derm Venereol; 1985; 65(3):230-4. PubMed ID: 2411079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic considerations on treatment of increased platelet aggregation in diabetic vasculopathic patients.
    Bizzi B; Leone G; Boni P
    Acta Diabetol Lat; 1974; 11(6):437-45. PubMed ID: 4469856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.